Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Robinson, Alyson Smith, K. Channer (2010)
Reversible heart failure: the role of inflammatory activationPostgraduate Medical Journal, 87
P. Jhund, K. MacIntyre, Colin Simpson, J. Lewsey, S. Stewart, A. Redpath, J. Chalmers, S. Capewell, J. McMurray (2009)
Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003: A Population Study of 5.1 Million PeopleCirculation, 119
J. Rocchiccioli, J. McMurray, A. Dominiczak (2010)
Biomarkers in heart failure: a clinical reviewHeart Failure Reviews, 15
S. Anker, S. Haehling (2004)
Inflammatory mediators in chronic heart failure: an overviewHeart, 90
(2019)
Variable SelectionModel-Based Clustering and Classification for Data Science
L. Felkin, E. Lara-Pezzi, Robert George, M. Yacoub, E. Birks, P. Barton (2009)
Expression of extracellular matrix genes during myocardial recovery from heart failure after left ventricular assist device support.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 28 2
G. Freue, Mayu Sasaki, Anna Meredith, O. Günther, Axel Bergman, Mandeep Takhar, A. Mui, R. Balshaw, R. Ng, Nina Opushneva, Z. Hollander, Guiyun Li, C. Borchers, Janet Wilson‐McManus, B. McManus, P. Keown, W. McMaster (2010)
Proteomic Signatures in Plasma during Early Acute Renal Allograft Rejection*Molecular & Cellular Proteomics : MCP, 9
J. Sharma (2006)
The kallikrein-kinin system: from mediator of inflammation to modulator of cardioprotectionInflammoPharmacology, 12
Z. Hollander, D. Lin, V. Chen, R. Ng, Janet Wilson‐McManus, A. Ignaszewski, Gabriela Freue, R. Balshaw, A. Mui, R. McMaster, P. Keown, B. McManus (2010)
Whole Blood Biomarkers of Acute Cardiac Allograft Rejection: Double-Crossing the BiopsyTransplantation, 90
F. Kramer, H. Milting (2011)
Novel biomarkers in human terminal heart failure and under mechanical circulatory supportBiomarkers, 16
Shamim Ahmad, P. Otaal, T. Rai, A. Bahl, U. Saikia, R. Manoj, M. Thungapathra, K. Talwar, M. Khullar (2008)
Circulating proinflammatory cytokines and N-terminal pro-brain natriuretic peptide significantly decrease with recovery of left ventricular function in patients with dilated cardiomyopathyMolecular and Cellular Biochemistry, 324
David Virginy (2006)
Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure : a clinical review.Heart failure reviews, 11 4
McMurray (2012)
Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of CardiologyEur J Heart Fail, 14
B. Wrigley, G. Lip, E. Shantsila (2011)
The role of monocytes and inflammation in the pathophysiology of heart failureEuropean Journal of Heart Failure, 13
G. Novo, G. Amoroso, G. Fazio, F. Sutera, S. Novo (2009)
Biomarkers in heart failure.Frontiers in bioscience, 14
R. McKelvie, G. Moe, J. Ezekowitz, George Heckman, J. Costigan, A. Ducharme, E. Estrella-Holder, N. Giannetti, A. Grzeslo, K. Harkness, J. Howlett, S. Kouz, K. Leblanc, E. Mann, A. Nigam, E. O’Meara, M. Rajda, B. Steinhart, E. Swiggum, Vy-van Le, S. Zieroth, J. Arnold, T. Ashton, M. D’Astous, P. Dorian, H. Haddad, D. Isaac, M. Leblanc, P. Liu, V. Rao, Heather Ross, B. Sussex (2013)
The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure.The Canadian journal of cardiology, 29 2
J. McMurray, S. Adamopoulos, S. Anker, A. Auricchio, M. Böhm, K. Dickstein, V. Falk, G. Filippatos, C. Fonseca, M. Gómez-Sánchez, T. Jaarsma, L. Køber, G. Lip, A. Maggioni, A. Parkhomenko, B. Pieske, B. Popescu, P. Rønnevik, F. Rutten, J. Schwitter, P. Seferovic, J. Stȩpińska, P. Trindade, A. Voors, F. Zannad, A. Zeiher, J. Bax, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, P. Kirchhof, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, Ž. Reiner, U. Sechtem, P. Sirnes, M. Tendera, A. Torbicki, A. Vahanian, S. Windecker, L. Bonet, P. Avraamides, Hisham Lamin, M. Brignole, A. Coca, P. Cowburn, H. Dargie, P. Elliott, F. Flachskampf, Guido Guida, S. Hardman, B. Iung, B. Merkely, C. Mueller, J. Nanas, O. Nielsen, S. Ørn, J. Parissis, P. Ponikowski (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012European Journal of Heart Failure, 14
Christopher Davis, PaulA Gurbel, W. Gattis, S. Fuzaylov, Girish Nair, Christopher O'Connor, V. Serebruany (2000)
Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge.International journal of cardiology, 75 1
C. Yancy, M. Jessup, B. Bozkurt, J. Butler, D. Casey, M. Drazner, G. Fonarow, S. Geraci, T. Horwich, J. Januzzi, Maryl Johnson, E. Kasper, W. Levy, F. Masoudi, P. Mcbride, J. McMurray, J. Mitchell, Pamela Peterson, B. Riegel, F. Sam, L. Stevenson, W. Tang, E. Tsai, B. Wilkoff (2013)
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Journal of the American College of Cardiology, 62 16
Braunwald (2008)
Biomarkers in heart failureN Engl J Med, 358
C. Yancy, M. Jessup, B. Bozkurt, J. Butler, D. Casey, M. Drazner, G. Fonarow, S. Geraci, T. Horwich, J. Januzzi, Maryl Johnson, E. Kasper, W. Levy, F. Masoudi, P. Mcbride, J. McMurray, J. Mitchell, Pamela Peterson, B. Riegel, F. Sam, L. Stevenson, W. Tang, E. Tsai, B. Wilkoff (2013)
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.Circulation, 128 16
Y. Higuchi, T. Kubota, M. Koyanagi, T. Maeda, A. Feldman, N. Makino (2012)
Upregulation of anticoagulant proteins, protein S and tissue factor pathway inhibitor, in the mouse myocardium with cardio-specific TNF-α overexpression.American journal of physiology. Heart and circulatory physiology, 302 11
K. Swedberg, J. Cleland, H. Dargie, H. Drexler, F. Follath, M. Komajda, L. Tavazzi, O. Smiseth, A. Gavazzi, A. Haverich, A. Hoes, T. Jaarsma, J. Korewicki, Samuel Lévy, C. Linde, J. López-Sendón, M. Nieminen, L. Pierard, W. Remme (2005)
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.European heart journal, 26 11
D. Mann (2002)
Inflammatory mediators and the failing heart: past, present, and the foreseeable future.Circulation research, 91 11
A. Pilbrow, B. Palmer, Chris Frampton, T. Yandle, R. Troughton, Elizabeth Campbell, L. Skelton, J. Lainchbury, A. Richards, Vicky Cameron (2007)
Angiotensinogen M235T and T174M Gene Polymorphisms in Combination Doubles the Risk of Mortality in Heart FailureHypertension, 49
G. Smyth (2004)
Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray ExperimentsStatistical Applications in Genetics and Molecular Biology, 3
A. Palazzuoli, G. Antonelli, Ilaria Quatrini, R. Nuti (2011)
Natriuretic peptides in heart failure: where we are, where we are goingInternal and Emergency Medicine, 6
G. Lip, C. Gibbs (1999)
Does heart failure confer a hypercoagulable state? Virchow's triad revisited.Journal of the American College of Cardiology, 33 5
J. Goeman, S. Geer, Floor Kort, H. Houwelingen (2004)
A global test for groups of genes: testing association with a clinical outcomeBioinformatics, 20 1
J. Tu, Lorelei Nardi, Jiming Fang, Juan Liu, Laila Khalid, H. Johansen (2009)
National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994–2004Canadian Medical Association Journal, 180
David Virginy (2006)
Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failureHeart Failure Reviews, 11
V. Roger, S. Weston, M. Redfield, Jens Hellermann-Homan, J. Killian, B. Yawn, S. Jacobsen (2004)
Trends in heart failure incidence and survival in a community-based population.JAMA, 292 3
A. Mongirdienė, L. Kuršvietienė, Artūras Kašauskas (2010)
The coagulation system changes in patients with chronic heart failure.Medicina, 46 9
M. Kuzyk, Derek Smith, Juncong Yang, Tyra Cross, A. Jackson, Darryl Hardie, N. Anderson, C. Borchers (2009)
Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma*Molecular & Cellular Proteomics, 8
K. Boengler, D. Hilfiker-Kleiner, H. Drexler, G. Heusch, R. Schulz (2008)
The myocardial JAK/STAT pathway: from protection to failure.Pharmacology & therapeutics, 120 2
Aims Chronic heart failure is a costly epidemic that affects up to 2% of people in developed countries. The purpose of this study was to discover novel blood proteomic biomarker signatures of recovered heart function that could lead to more effective heart failure patient management by both primary care and specialty physicians. Methods and results The discovery cohort included 41 heart transplant patients and 20 healthy individuals. Plasma levels of 138 proteins were detected in at least 75% of these subjects by iTRAQ mass spectrometry. Eighteen proteins were identified that had (i) differential levels between pre‐transplant patients with end‐stage heart failure and healthy individuals; and (ii) levels that returned to normal by 1 month post‐transplant in patients with stable heart function after transplantation. Seventeen of the 18 markers were validated by multiple reaction monitoring mass spectrometry in a cohort of 39 heart failure patients treated with drug therapy, of which 30 had recovered heart function and 9 had not. This 17‐protein biomarker panel had 93% sensitivity and 89% specificity, while the RAMP® NT‐proBNP assay had the same specificity but 80% sensitivity. Performance further improved when the panel was combined with NT‐proBNP, yielding a net reclassification index relative to NT‐proBNP of 0.28. Conclusions We have identified potential blood biomarkers of recovered heart function by harnessing data from transplant patients. These biomarkers can lead to the development of an inexpensive protein‐based blood test that could be used by physicians to monitor response to therapy in heart failure, resulting in more personalized, front‐line heart failure patient management.
European Journal of Heart Failure – Wiley
Published: May 1, 2014
Keywords: ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.